{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T23:15:48Z","timestamp":1772147748617,"version":"3.50.1"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,15]]},"DOI":"10.1093\/hmg\/ddx357","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T11:10:24Z","timestamp":1505301024000},"page":"4778-4785","source":"Crossref","is-referenced-by-count":13,"title":["Suppression of leptin signaling reduces polyglucosan inclusions and seizure susceptibility in a mouse model for Lafora disease"],"prefix":"10.1093","volume":"26","author":[{"given":"Anupama","family":"Rai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9908-9177","authenticated-orcid":false,"given":"Subramaniam","family":"Ganesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,9,14]]},"reference":[{"key":"key\n\t\t\t\t20171201025812_ddx357-B1","doi-asserted-by":"crossref","first-page":"514","DOI":"10.4103\/0028-3886.68660","article-title":"Progressive myoclonic epilepsy","volume":"58","year":"2010","journal-title":"Neurol. India"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1750-3639.2009.00308.x","article-title":"22-year-old girl with status epilepticus and progressive neurological symptoms","volume":"19","year":"2009","journal-title":"Brain Pathol"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B3","first-page":"1","article-title":"Lafora disease: a quantitative morphological and biochemical study of the cerebral cortex","volume":"6","year":"1987","journal-title":"Clin. Neuropathol"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mam.2015.08.003","article-title":"Glycogen phosphorylation and Lafora disease","volume":"46","year":"2015","journal-title":"Mol. Aspects Med"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/ana.22156","article-title":"Glycogen hyperphosphorylation underlies Lafora body formation","volume":"68","year":"2010","journal-title":"Ann. Neurol"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B6","doi-asserted-by":"crossref","first-page":"19262","DOI":"10.1073\/pnas.0707952104","article-title":"Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo","volume":"104","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10038-005-0321-1","article-title":"Recent advances in the molecular basis of Lafora's progressive myoclonus epilepsy","volume":"51","year":"2006","journal-title":"J. Hum. Genet"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B8","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/hmg\/11.11.1251","article-title":"Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice","volume":"11","year":"2002","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ana.23899","article-title":"Inhibiting glycogen synthesis prevents Lafora disease in a mouse model","volume":"74","year":"2013","journal-title":"Ann. Neurol"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B10","doi-asserted-by":"crossref","first-page":"e1002037.","DOI":"10.1371\/journal.pgen.1002037","article-title":"PTG depletion removes Lafora bodies and rescues the fatal epilepsy of Lafora disease","volume":"7","year":"2011","journal-title":"PLoS Genet"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B11","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/hmg\/ddu024","article-title":"Glycogen accumulation underlies neurodegeneration and autophagy impairment in Lafora disease","volume":"23","year":"2014","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B12","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1128\/MCB.06353-11","article-title":"The laforin-malin complex negatively regulates glycogen synthesis by modulating cellular glucose uptake via glucose transporters","volume":"32","year":"2012","journal-title":"Mol. Cell Biol"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1152\/physrev.00007.2010","article-title":"Leptin and the central nervous system control of glucose metabolism","volume":"91","year":"2011","journal-title":"Physiol. Rev"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B14","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1210\/en.2005-1464","article-title":"Insulin and leptin induce Glut4 plasma membrane translocation and glucose uptake in a human neuronal cell line by a phosphatidylinositol 3-kinase- dependent mechanism","volume":"147","year":"2006","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B15","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.2337\/diabetes.48.6.1264","article-title":"Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob\/ob mice","volume":"48","year":"1999","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B16","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/38717","article-title":"Acute stimulation of glucose metabolism in mice by leptin treatment","volume":"389","year":"1997","journal-title":"Nature"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/1573399810666140508121012","article-title":"Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes","volume":"10","year":"2014","journal-title":"Curr. Diabetes Rev"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B18","first-page":"291","article-title":"Enhanced sensitivity of laforin- and malin-deficient mice to the convulsant agent pentylenetetrazole","volume":"8","year":"2014","journal-title":"Front. Neurosci"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B19","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/hmg\/ddr598","article-title":"Laforin and malin knockout mice have normal glucose disposal and insulin sensitivity","volume":"21","year":"2012","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B20","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1126\/science.271.5251.994","article-title":"Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor","volume":"271","year":"1996","journal-title":"Science"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0092-8674(00)81294-5","article-title":"Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db\/db mice","volume":"84","year":"1996","journal-title":"Cell"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.abb.2006.10.017","article-title":"Glycogen metabolism in tissues from a mouse model of Lafora disease","volume":"457","year":"2007","journal-title":"Arch. Biochem. Biophys"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF00688087","article-title":"Progressive familial myoclonic epilepsy with Lafora bodies. Electron microscopic and histochemical study of a cerebral biopsy","volume":"7","year":"1967","journal-title":"Acta. Neuropathol"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/hmg\/ddr452","article-title":"Dysfunctions in endosomal-lysosomal and autophagy pathways underlie neuropathology in a mouse model for Lafora disease","volume":"21","year":"2012","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/emmm.201100174","article-title":"Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease","volume":"3","year":"2011","journal-title":"EMBO Mol. Med"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B26","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1093\/hmg\/ddq407","article-title":"Sequestration of chaperones and proteasome into Lafora bodies and proteasomal dysfunction induced by Lafora disease-associated mutations of malin","volume":"19","year":"2010","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B27","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1007\/s12035-016-9884-4","article-title":"Inflammation in Lafora Disease: Evolution with Disease Progression in Laforin and Malin Knock-out Mouse Models","volume":"54","year":"2017","journal-title":"Mol. Neurobiol"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B28","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/hmg\/ddr590","article-title":"Lafora bodies and neurological defects in malin-deficient mice correlate with impaired autophagy","volume":"21","year":"2012","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0009-8981(75)90093-5","article-title":"Biochemical studies on tissues from a patient with Lafora disease","volume":"62","year":"1975","journal-title":"Clin. Chim. Acta"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/archneur.1968.00480010033002","article-title":"Studies in myoclonus epilepsy (Lafora body form). I. Isolation and preliminary characterization of Lafora bodies in two cases","volume":"19","year":"1968","journal-title":"Arch. Neurol"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B31","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/35007534","article-title":"Central nervous system control of food intake","volume":"404","year":"2000","journal-title":"Nature"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B32","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1172\/JCI64102","article-title":"Leptin regulates glutamate and glucose transporters in hypothalamic astrocytes","volume":"122","year":"2012","journal-title":"J. Clin. Invest"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B33","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/epi.13656","article-title":"Sodium selenate treatment improves symptoms and seizure susceptibility in a malin-deficient mouse model of Lafora disease","volume":"58","year":"2017","journal-title":"Epilepsia"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B34","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.molmet.2015.08.005","article-title":"Leptin potentiates astrogenesis in the developing hypothalamus","volume":"4","year":"2015","journal-title":"Mol. Metab"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mam.2015.08.007","article-title":"Brain glycogen in health and disease","volume":"46","year":"2015","journal-title":"Mol. Aspects. Med"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B36","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/iub.1072","article-title":"Deciphering the role of malin in the lafora progressive myoclonus epilepsy","volume":"64","year":"2012","journal-title":"IUBMB Life"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B37","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/13816128113199990014","article-title":"Novel superactive leptin antagonists and their potential therapeutic applications","volume":"20","year":"2014","journal-title":"Curr. Pharm. Des"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.nbd.2017.01.002","article-title":"Loss of laforin or malin results in increased Drp1 level and concomitant mitochondrial fragmentation in Lafora disease mouse models","volume":"100","year":"2017","journal-title":"Neurobiol. Dis"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B39","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.1523\/JNEUROSCI.19-16-06733.1999","article-title":"Mapping loci for pentylenetetrazol-induced seizure susceptibility in mice","volume":"19","year":"1999","journal-title":"J. Neurosci"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B40","doi-asserted-by":"crossref","first-page":"13543","DOI":"10.1074\/jbc.M114.553321","article-title":"Decreased O-linked GlcNAcylation protects from cytotoxicity mediated by huntingtin exon1 protein fragment","volume":"289","year":"2014","journal-title":"J. Biol. Chem"},{"key":"key\n\t\t\t\t20171201025812_ddx357-B41","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1091\/mbc.E13-05-0261","article-title":"Activation of serum\/glucocorticoid-induced kinase 1 (SGK1) underlies increased glycogen levels, mTOR activation, and autophagy defects in Lafora disease","volume":"24","year":"2013","journal-title":"Mol. Biol. Cell"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/26\/24\/4778\/22092660\/ddx357.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T22:38:49Z","timestamp":1719441529000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/hmg\/article\/26\/24\/4778\/4158144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,14]]},"references-count":41,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2017,9,14]]},"published-print":{"date-parts":[[2017,12,15]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddx357","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,12,15]]},"published":{"date-parts":[[2017,9,14]]}}}